Treating hypertension – a new approach
Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians.
Research has indicated that a new pharmacological...
Experts urge support for PrEP after second Australian HIV case
Experts are emphasising the efficacy of the revolutionary pre-exposure prophylaxis (PrEP) medicine after a recent case of a Sydney man contracting HIV while taking...
Vale FIP President Dominique Jordan
Tributes have been paid to International Pharmaceutical Federation President Mr Dominique Jordan, who sadly passed away on 19 August.
Call for pharmacist access to the MBS for Chronic Disease Management
Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense.
After a...
Ensuring patients’ medical data is secure
The rollout of My Health Record has raised questions surrounding the security of medical data. What measures must be taken in pharmacies to preserve...
Harnessing different abilities
Some might assume employing someone with a declared disability would only bring complications. But some community pharmacies around Australia are leading the way in...













